Manuscripts

Search by keyword, year, or author name.

Showing 1533 manuscripts.

Quality of life for children and adolescents: impact of HIV infection and antiretroviral treatment.

Grace M. Lee, Steven Gortmaker, Kenneth McIntosh, Michael Hughes, James M. Oleske. Quality of life for children and adolescents: impact of HIV infection and antiretroviral treatment.. Pediatrics. 2006. 117: 273-283.

Year

2006

Journal

Pediatrics

Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy.

Nathalie Ylitalo, Susan Brogly, Michael Hughes, Sharon Appelbaum Nachman, Wayne M. Dankner, Russell B. Van Dyke, George Seage. Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy.. Archives of Pediatrics and Adolescent Medicine. 2006. 160: 778 - 787. PMID: 16894075

Year

2006

Journal

Archives of Pediatrics and Adolescent Medicine

HIV-1 vaccine induced immune responses in newborns of HIV-1 infected mothers.

Elizabeth (Betsy) J. McFarland, Daniel Johnson, Petronella Muresan, Terence Fenton, Georgia D. Tomaras, James McNamara, Jennifer S. Read, Steven D. Douglas, Jaime G. Deville, Marc Gurwith, Sanjay Gurunathan, John S. Lambert. HIV-1 vaccine induced immune responses in newborns of HIV-1 infected mothers.. AIDS. 2006. 20: 1481 - 1489.

Year

2006

Journal

AIDS

Susceptibility of pediatric HIV-1 isolates to recombinant CD4-IgG2 (PRO 542) and humanized mAb to the chemokine receptor CCR5 (PRO 140)

William T. Shearer, Jaime G. Deville, Pearl Samson, John ( Jack ) Moye, Courtney V. Fletcher, Joseph A. Church, Hans ML Spiegel, Paul Palumbo, Terence Fenton, Elizabeth (Betsy) Smith, Bobbie L. Graham, William C. Olson. Susceptibility of pediatric HIV-1 isolates to recombinant CD4-IgG2 (PRO 542) and humanized mAb to the chemokine receptor CCR5 (PRO 140). Journal of Allergy and Clinical Immunology. 2006. 118: 518 - 521. PMID: 16890780

Year

2006

Journal

Journal of Allergy and Clinical Immunology

Neuropsychiatric complications of antiretroviral therapy

Michelle S. Cespedes, Judith A. Aberg. Neuropsychiatric complications of antiretroviral therapy. Drug Safety. 2006. 29: 865-74.

Year

2006

Journal

Drug Safety

Changes in the slope of the CD4 cell count increase after initiation of potent antiretroviral treatment

Ronald J. Bosch, Rui Wang, Florin Vaida, Michael M. Lederman, Mary Albrecht. Changes in the slope of the CD4 cell count increase after initiation of potent antiretroviral treatment. Journal of Acquired Immune Deficiency Syndromes. 2006. 43: 433-5.

Year

2006

Journal

Journal of Acquired Immune Deficiency Syndromes

Activity of newer triazoles against histoplasma capsulatum from patients with AIDS who failed fluconazole

L. Joseph Wheat, Patricia A. Connolly, Melinda L. Smedema, Michelle M. Durkin, Edward Brizendine, Paul Mann, Reena Patel, Paul McNicholas, Mitchell (Mitch) Goldman. Activity of newer triazoles against histoplasma capsulatum from patients with AIDS who failed fluconazole. Journal of Antimicrobial Chemotherapy. 2006. 57: 1235-9. PMID: 16627592

Year

2006

Journal

Journal of Antimicrobial Chemotherapy

Cyclosporin A provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy: results of a randomized, controlled trial of the AIDS clinical trials group A5138

Michael M. Lederman, Laura Smeaton, Kimberly Y. Smith, Benigno Rodriguez, Minya Pu, Hongying Wang, Anne Sevin, Pablo Tebas, Scott F. Sieg, Kathleen A. Medvik, David M. Margolis, Richard B. Pollard, Hildegund Ertl, Hernan Valdez. Cyclosporin A provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy: results of a randomized, controlled trial of the AIDS clinical trials group A5138. Journal of Infectious Diseases. 2006. 194: 1677-85.

Year

2006

Journal

Journal of Infectious Diseases